Table 3.
Group C (n = 31) | Group B (n = 31) | Group BD (n = 31) | p | |
---|---|---|---|---|
Patient satisfaction scores | ||||
Very dissatisfied | 0 (0) | 1 (3.2) | 0 (0) | |
Somewhat satisfied | 12 (39.8) | 4 (12.9)a | 0 (0)a,b | <0.001 |
Rather satisfied | 19 (61.3) | 18(58.1) | 17 (54.8) | |
Completely satisfied | 0 (0) | 8 (25.8)a | 14 (45.1)a | |
Nausea and vomiting | ||||
None | 17 (54.8) | 22 (71.0) | 21 (65.6) | |
Nausea | 7 (22.6) | 3 (9.7) | 6 (21.9) | 0.129 |
Retching | 6 (19.4) | 5 (16.1) | 4 (12.5) | |
Vomiting | 1 (0.7) | 1 (0.7) | 0 (0) | |
Patients receiving antiemetics (n) | ||||
0–2 h | 7 (22.6) | 5 (16.1) | 5 (16.1) | 0.313 |
2–6 h | 5 (16.1) | 4 (12.9) | 4 (12.9) | 0.428 |
6–12 h | 3 (9.7) | 2 (6.5) | 1 (3.2) | 0.224 |
12–24 h | 0 (0) | 1 (3.2) | 0 (0) | 0.667 |
C, control; B, bupivacaine; BD, bupivacaine + dexmedetomidine.
Significant difference from Group C.
Significant difference from Group B.